Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075346 · ClinicalTrials.gov registry record
Bedside Respiratory Patient Monitoring System - Sensor Off Study
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 18
- Enrollment target
NCT02075346: Completed study, sponsored by Medtronic - MITG.
NCT02075346 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02075346 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Use of an investigational oximetry system to evaluate the triggering of the "sensor off" status with the marketed off-the-shelf sensors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-11 |
| Est. Completion | 2013-11 |
What the finished NCT02075346 record still lists
NCT02075346 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02075346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02075346 about?
NCT02075346 is a clinical study titled "Bedside Respiratory Patient Monitoring System - Sensor Off Study". Use of an investigational oximetry system to evaluate the triggering of the "sensor off" status with the marketed off-the-shelf sensors.
What is the current status of trial NCT02075346?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2013-11. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT02075346?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia